Global MEMS Ophthalmic Drug Delivery System Market Growth 2025-2031

The global MEMS Ophthalmic Drug Delivery System market size is predicted to grow from US$ 335 million in 2025 to US$ 427 million in 2031; it is expected to grow at a CAGR of 4.1% from 2025 to 2031.

MEMS (Micro-Electro-Mechanical Systems) ophthalmic drug delivery system is an ocular drug delivery system designed using micro-electro-mechanical systems technology. This kind of system usually has the characteristics of small size, strong function, low price and high reliability. Among them, the micropump serves as the "heart" of the microsystem and provides the main power for fluid transportation.

United States market for MEMS Ophthalmic Drug Delivery System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for MEMS Ophthalmic Drug Delivery System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for MEMS Ophthalmic Drug Delivery System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key MEMS Ophthalmic Drug Delivery System players cover Mati Therapeutics, Amorphex Therapeutics, Aero Pump GmbH, AptarGroup, Bausch Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “MEMS Ophthalmic Drug Delivery System Industry Forecast” looks at past sales and reviews total world MEMS Ophthalmic Drug Delivery System sales in 2024, providing a comprehensive analysis by region and market sector of projected MEMS Ophthalmic Drug Delivery System sales for 2025 through 2031. With MEMS Ophthalmic Drug Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world MEMS Ophthalmic Drug Delivery System industry.

This Insight Report provides a comprehensive analysis of the global MEMS Ophthalmic Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on MEMS Ophthalmic Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global MEMS Ophthalmic Drug Delivery System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for MEMS Ophthalmic Drug Delivery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global MEMS Ophthalmic Drug Delivery System.

This report presents a comprehensive overview, market shares, and growth opportunities of MEMS Ophthalmic Drug Delivery System market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Ophthalmic Mini Pump
Ophthalmic Injection Needle
Implantable Gel
Others

Segmentation by Application:
Hospital
Clinic
Home

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Mati Therapeutics
Amorphex Therapeutics
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson & Company
EyePoint Pharmaceuticals, inc.
Gaplast GmbH
Gerresheimer
Nemera
Nipro Corporation
Ocular Therapeutix

Key Questions Addressed in this Report

What is the 10-year outlook for the global MEMS Ophthalmic Drug Delivery System market?

What factors are driving MEMS Ophthalmic Drug Delivery System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do MEMS Ophthalmic Drug Delivery System market opportunities vary by end market size?

How does MEMS Ophthalmic Drug Delivery System break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.